Larimar Therapeutics, Inc. (LRMR)
3.935
+0.08
(+2.21%)
USD |
NASDAQ |
Sep 11, 16:00
3.935
0.00 (0.00%)
After-Hours: 16:53
Larimar Therapeutics Gross Profit (TTM) : -0.301M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.301M |
| March 31, 2026 | -0.326M |
| December 31, 2025 | -0.35M |
| September 30, 2025 | -0.34M |
| June 30, 2025 | -0.326M |
| March 31, 2025 | -0.326M |
| December 31, 2024 | -0.318M |
| September 30, 2024 | -0.322M |
| June 30, 2024 | -0.317M |
| March 31, 2024 | -0.279M |
| December 31, 2023 | -0.253M |
| September 30, 2023 | -0.204M |
| June 30, 2023 | -0.212M |
| March 31, 2023 | -0.244M |
| December 31, 2022 | -0.272M |
| September 30, 2022 | -0.328M |
| June 30, 2022 | -0.339M |
| March 31, 2022 | -0.335M |
| December 31, 2021 | -0.326M |
| September 30, 2021 | -0.288M |
| June 30, 2021 | -0.25M |
| March 31, 2021 | -0.173M |
| December 31, 2020 | -0.123M |
| September 30, 2020 | -0.093M |
| June 30, 2020 | -0.063M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.063M |
| December 31, 2019 | -0.091M |
| September 30, 2019 | -0.123M |
| June 30, 2019 | -0.21M |
| March 31, 2019 | -0.262M |
| December 31, 2018 | -0.261M |
| September 30, 2018 | -0.259M |
| June 30, 2018 | -0.201M |
| March 31, 2018 | -0.197M |
| December 31, 2017 | -0.188M |
| September 30, 2017 | -0.199M |
| June 30, 2017 | -0.199M |
| March 31, 2017 | -0.203M |
| December 31, 2016 | -0.212M |
| September 30, 2016 | -0.194M |
| June 30, 2016 | -0.158M |
| March 31, 2016 | -0.115M |
| December 31, 2015 | -0.07M |
| September 30, 2015 | -0.033M |
| June 30, 2015 | -0.024M |
| March 31, 2015 | -0.015M |
| December 31, 2014 | -0.013M |
| September 30, 2014 | -0.007M |
| June 30, 2014 | -0.005M |
| March 31, 2014 | -0.005M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| SELLAS Life Sciences Group, Inc. | 0.00 |
| Marker Therapeutics, Inc. | 0.00 |
| Rezolute, Inc. | -0.031M |
| Krystal Biotech, Inc. | 411.03M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |